PR

Print

 

   pr

Novartis 5-year data in psoriatic arthritis
and ankylosing spondylitis 
reinforces
Cosentyx leadership in spondyloarthritis

BASEL:Novartis, a leader in immuno-dermatology and rheumatology has  announced that it will be presenting five-year data from the ongoing extensions of the phase III FUTURE 1 and MEASURE 1 studies for Cosentyx® (secukinumab) in patients with psoriatic arthritis (PsA) and ankylosing spondylitis (AS) respectively. These new data will be presented at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting in Chicago, United States. 

"AS and PsA have a significant impact on the quality of patients' lives, and they require a comprehensive treatment which targets all of the manifestations of their disease," said Professor Georg A. Schett, Professor and Chair, Department of Medicine, Rheumatology and Immunology at University of Erlangen-Nuremberg. "The presentation of long-term data in PsA and AS supports the central role of Cosentyx in the long-term sustained management of these complex and multi-faceted conditions."

New long-term data from FUTURE 1 and MEASURE 1 confirm that Cosentyx provides sustained improvements in the signs and symptoms of PsA and AS out to five years In FUTURE 1, 83% and 94% of PsA patients achieved total resolution of enthesitis and dactylitis, respectively. Over 80% of patients who entered the extension phases of both studies completed five years with a safety profile consistent with previous reports. These data add to findings from the SCULPTURE study, in which two thirds of patients on Cosentyx reported no impact of skin disease on their quality of life over five years.

PsA and AS are both debilitating, chronic and progressive conditions, which can significantly impact mobility and consequently patients' quality of life. As a result, patients and physicians are increasingly looking for treatments that show long-lasting efficacy with a favourable safety profile. Cosentyx delivers long-lasting, comprehensive treatment through targeted inhibition of IL-17A, a cornerstone cytokine involved in the development of spondyloarthritis and psoriatic diseases.

Five-year data is often seen as a benchmark for proving long-term efficacy and safety, said Eric Hughes, Global Development Unit Head, Immunology, Hepatology and Dermatology. "By adding five-year data in PsA and AS to the already reported five-year data in psoriasis, we are reinforcing the robust profile of Cosentyx and reimagining the standard of care for patients who search for a complete treatment for spondyloarthritis and psoriatic disease.(PR)


World Stroke Day meeting at BMU

Specialized Stroke Units should
be established at majors cities

KARACHI: Stroke is quite common and results in much more fatality as compared to man y other diseases. This was stated by Prof. Arif Herekar while speaking at the World Stroke Day meeting held at Baqai Medical University recently. In United States there are about eight hundred thousand patients presenting with stroke every year out of which six hundred thousand are new patients and under two hundred thousand are recurrent strokes.

Prof. Jamil Ahmed Dean of faculty of Medicine Baqai medical University spoke about the risk factors and diet emphasizing on the importance of creating awareness amongst the local population According to him the symptomatology of stroke should be known to not only doctors but paramedics as well. Emphasizing the need for specialized stroke unit in Pakistan which are far and few, prevention of stroke is more important than trying to treat disability due to stroke, he added. He was of the view that 40% stroke incidence can be reduced just buy managing high blood pressure.

Prof. Arif also spoke about the increasing obesity, use of junk food hypercholesterolemia, diabetes smoking and collagen diseases especially in the young. Exercise is also very important.

He also emphasized the importance of setting up specialized stroke centers in Pakistan. He also highlighted the efficacy of thrombolytic therapy such as TPA. He also discussed mechanical thrombectomy which can save many lives and disability. Mechanical thrombectomy needs specialized units and expertise which are not available in our country but needs to be made available. Use of high fiber diet can help in prevention of strokes by reducing weight and lowering cholesterol. Women suffer twice as much stroke as men due to a longer life span. (PR)


DUHS DICE Innovation
Exhibition 2018

KARACHI: Research in Pharma industry is very expensive, world's largest companies have invested in mutual interest and research, but it did not prove to be fruitful. Medications could be prepared by natural herbs in Pakistan and India but in the past period, it was not paid any heed. Although it is a very affordable research, it is now been focused upon and desired results are obtained. These views were expressed by Sardar Yaseen Malik speaking as special guest in the closing ceremony of Dow University of Health Sciences DICE Health Innovation Exhibition, 2018.

Prof. Dr. Saeed Qureshi, the Vice Chancellor of Dow University of Health Sciences, Pro Vice Chancellor Dr. Mohammad Masroor, Prof. Dr. Zarnaz Wahid, Chairman of DICE Foundation, Khursheed Qureshi, Dr. Sohail Hassan, Adil Jamal Akhtar, Senior Faculty Members and a large number of students were present at the occasion.

Sardar Yaseen Malik further said that not only Pakistan but the future of medicines made from natural ingredients around the world is very bright, while raw materials are also available for this purpose in Pakistan and India. He further said that conducting research and making its prototype are two different things while practically the use of this research is exactly another thing, we need to focus on the practical use of it on industry level. (PR)


DAP to organize World Diabetes
Day on November 18, 2018

KARACHI. The Diabetic Association of Pakistan (DAP) and World Health Organization (WHO) Collaborating Centre, Karachi is holding World Diabetes Day (WDD) 2018 in Karachi, November 18, 2018. The Scientific session in the morning is meant for doctors. Experts will deliver state of the art lectures on the treatment and prevention of diabetes and complications. The afternoon session is for the people with diabetes and their family members.

‘The Family and Diabetes’ is the world Diabetes Day theme for 2018-2019. The campaign will aim to raise awareness of the impact that diabetes has on the family and support network of those affected, promote the role of the family in the management, care, prevention and education of diabetes. For details contact: Phone: 36616890 Fax no: 36680959 Mobile: 0333-3407183 Email: This email address is being protected from spambots. You need JavaScript enabled to view it. (PR)

© Professional Medical Publications. All rights reserved.